Clover Health Investments, Corp. (CLOV) stock

CLOVNasdaqHospital & Medical Service PlansFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30

$4.88−0.09 (-1.81%)

Close on Nov 12, 2026Market cap $2.59BP/E 488.0Yield –

Clover Health Investments r&d expenses

Research and development expenses are spending on new products and technology.

Clover Health Investments has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in Clover Health Investments's annual and quarterly filings with the SEC
Per-share figures adjusted for the 19-for-3 split on May 17, 2021
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing